Fermenta Biotech Gets FSSAI Green Light for Plant-Based Vitamin D3 Product
Fermenta Biotech Limited has received FSSAI approval for VITADEE Green®, its plant-based Vitamin D3 (Cholecalciferol) product, permitting its use in health supplements, nutraceuticals, and food items. Developed and manufactured entirely in India, the product supports the Make in India initiative and strengthens domestic nutritional self-reliance. The regulatory disclosure was filed with BSE Limited on July 3, 2026.

*this image is generated using AI for illustrative purposes only.
Fermenta Biotech Limited has secured approval from the Food Safety and Standards Authority of India (FSSAI) for its plant-based Vitamin D3 product, VITADEE Green®. This regulatory clearance enables the company to market its Vitamin D3 (Cholecalciferol) – Plant Source, a product developed and manufactured entirely within India. The approved product is permitted for use in health supplements, nutraceuticals, and food items, broadening its application across India's nutrition landscape. The approval supports the Make in India initiative and enhances the nation's self-reliance in nutrition solutions.
Regulatory Filing Details
The company informed BSE Limited regarding this development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was officially submitted on July 3, 2026.
Product and Strategic Impact
The newly approved VITADEE Green® represents a significant addition to Fermenta Biotech's portfolio. The following table summarises the key details of the approved product and its regulatory context:
| Parameter: | Details |
|---|---|
| Product Name: | VITADEE Green® |
| Product Type: | Vitamin D3 (Cholecalciferol) – Plant Source |
| Approved Applications: | Health Supplements, Nutraceuticals, Food Items |
| Regulatory Authority: | Food Safety and Standards Authority of India (FSSAI) |
| Manufacturing Origin: | Domestically developed and manufactured in India |
| Disclosure Filed With: | BSE Limited |
| Filing Date: | July 3, 2026 |
By manufacturing this plant-based Vitamin D3 domestically and enabling its use across multiple nutrition categories, Fermenta Biotech aims to contribute to the government's vision of local production and reduced dependency on imports for critical nutritional ingredients.
Historical Stock Returns for Fermenta Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.74% | -5.96% | +21.94% | +35.69% | +35.69% | +35.69% |
How will the cost structure of VITADEE Green® compare to imported animal-based Vitamin D3 alternatives?
What are the company's plans for international regulatory approvals to export this plant-based product?
Which major nutraceutical and food companies are expected to adopt VITADEE Green® following this approval?


































